Pharmacology aspects during transition and at transfer in patients with epilepsy

Epilepsia

Volumn 55, Issue s3, 2014, Pages 8-11

  Chiron, Catherine ^a   An, Isabelle ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Antiepileptic treatment; Children; Epilepsy; Transfer to adulthood; Transition

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; OXCARBAZEPINE; TOPIRAMATE; VIGABATRIN;

ARTICLE; CHILDHOOD ABSENCE EPILEPSY; CLINICAL ARTICLE; COHORT ANALYSIS; COMPLEX PARTIAL SEIZURE; CORTICAL DYSPLASIA; DISEASE EXACERBATION; DISEASE SEVERITY; EPILEPSY; FOCAL EPILEPSY; FOLLOW UP; GENERALIZED EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; MYOCLONUS EPILEPSY; PATIENT TRANSPORT; PLACEBO EFFECT; RELAPSE; RETROSPECTIVE STUDY; SEVERE MYOCLONIC EPILEPSY IN INFANCY; VISUAL FIELD DEFECT; ANTICONVULSANT THERAPY; CHILD; CLINICAL TRIAL (TOPIC); PSYCHOLOGICAL ASPECT; REVIEW; TRANSFER TO ADULTHOOD; TRANSITION; TRANSITION TO ADULT CARE; TREATMENT OUTCOME;

ANTIEPILEPTIC TREATMENT; CHILDREN; EPILEPSY; TRANSFER TO ADULTHOOD; TRANSITION;

ANTICONVULSANTS; CLINICAL TRIALS AS TOPIC; EPILEPSY; HUMANS; TRANSITION TO ADULT CARE; TREATMENT OUTCOME; VIGABATRIN;

EID: 84908373950     PISSN: 00139580     EISSN: 15281167     Source Type: Journal    
DOI: 10.1111/epi.12708     Document Type: Article

References (13)

1. Hernández-Díaz S, Smith CR, Shen A, et al. North American AED Pregnancy Registry. Comparative safety of antiepileptic drugs during pregnancy. Neurology 2012;78:1692-1699.
2. Chiron C, Dulac O, Pons G. Antiepileptic drug development in children: considerations for a revisited strategy. Drugs 2008;68:17-25.
3. Elterman RD, Glauser TA, Wyllie E, et al. A double-blind, randomized trial of topiramate as adjunctive therapy for partial-onset seizures in children. Topiramate YP Study Group. Neurology 1999;52:1338-1344.
4. Duchowny M, Pellock JM, Graf WD, et al. A placebo-controlled trial of lamotrigine add-on therapy for partial seizures in children. Lamictal Pediatric Partial Seizure Study Group. Neurology 1999;53:1724-1731.
5. Glauser TA, Nigro M, Sachdeo R, et al. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group. Neurology 2000;54:2237-2244.
6. Appleton R, Fichtner K, LaMoreaux L, et al. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group. Epilepsia 1999;40:1147-1154.
7. Glauser TA, Ayala R, Elterman RD, et al. Double-blind placebo-controlled trial of adjunctive levetiracetam in pediatric partial seizures. Neurology 2006;66:1654-1660.
8. Rheims S, Cucherat M, Arzimanoglou A, et al. Greater response to placebo in children than in adults: a systematic review and meta-analysis in drug-resistant partial epilepsy. PLoS Med 2008;5:e166.
9. Sillanpää M. Children with epilepsy as adults: outcome after 30 years of follow-up. Acta Paediatr Scand Suppl 1990;368:1-78.
10. Sillanpää M, Schmidt D. Early seizure frequency and aetiology predict long-term medical outcome in childhood-onset epilepsy. Brain 2009;132:989-998.
11. Wirrell EC, Camfield CS, Camfield PR, et al. Long-term prognosis of typical childhood absence epilepsy: remission or progression to juvenile myoclonic epilepsy. Neurology 1996;47:912-918.
12. Camfield CS, Camfield PR. The adult seizure and social outcomes of children with partial complex seizures. Brain 2013;136:593-600.
13. Catarino CB, Liu JY, Liagkouras I, et al. Dravet syndrome as epileptic encephalopathy: evidence from long-term course and neuropathology. Brain 2011;134:2982-3010.